Company Offers Most Comprehensive, Cost-Effective Suite of Solutions to Detect and Screen for Methicillin Resistant Staphylococcus aureus (MRSA) “bioMérieux is committed to bringing innovative ...
Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...
NucliSENS EasyQ® HPV, a molecular diagnostic test for the detection of human papillomavirus used in the prevention of cervical cancer. Cervical cancer is the leading cause of cancer-related deaths ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results